IMV INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IMV INC and buy or sell other stocks, ETFs, and their options commission-free!About IMVIF
IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response.
CEOAndrew Hall
CEOAndrew Hall
Employees—
Employees—
HeadquartersDartmouth, Nova Scotia
HeadquartersDartmouth, Nova Scotia
Founded2007
Founded2007
Employees—
Employees—
IMVIF Key Statistics
Market cap0.00
Market cap0.00
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume209.20
Average volume209.20
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume1.05K
Volume1.05K
52 Week high$0.0195
52 Week high$0.0195
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
As of today, IMV INC(IMVIF) shares are valued at $0.00. The company's market cap stands at 0.
During the trading day, IMV INC(IMVIF) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for IMV INC(IMVIF) stock has reached 1.05K, versus its average volume of 209.2.
The stock's 52-week range extends from a low of $0.00 to a high of $0.02.
The stock's 52-week range extends from a low of $0.00 to a high of $0.02.
People also own
Based on the portfolios of people who own IMVIF. This list is generated using Robinhood data, and it’s not a recommendation.